Affordable Access

deepdyve-link
Publisher Website

Prevalence of treatment with glaucoma medication in Scotland, 2010-2017.

Authors
  • Rotchford, Alan P1
  • Hughes, John2
  • Agarwal, Pankaj Kumar3
  • Tatham, Andrew J3
  • 1 Ophthalmology, Tennent Institute of Ophthalmology, Gartnavel Hospital, Glasgow, UK [email protected]
  • 2 International Glaucoma Association, Ashford, Kent, UK.
  • 3 Ophthalmology, Princess Alexandra Eye Pavilion, Edinburgh, UK.
Type
Published Article
Journal
British Journal of Ophthalmology
Publisher
BMJ
Publication Date
Mar 01, 2020
Volume
104
Issue
3
Pages
381–385
Identifiers
DOI: 10.1136/bjophthalmol-2019-314206
PMID: 31097436
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

To report the number and demographic distribution of patients receiving intraocular pressure (IOP)-lowering medications across the whole population of Scotland for the years 2010-2017 and, using national census data, show how the observed changes compare with those predicted by the increasing age of the population structure over this period. Data were sourced from the Prescribing Information System of the NHS Information and Statistics Division for Scotland. The number of patients dispensed any IOP-lowering medication from a community pharmacy during each calendar year was collected by gender and by 5-year age bands. National census data were used to model the expected annual increase in treatment numbers due to population ageing. The number of treated patients in 2017 was 61 249 which represents 1.13% of the whole population (or 2.16% over 40 years of age). The number increased from 48 178 in 2010-an increase over this period of 27.13% (3.88% per year).Prevalence increased with age, reaching 10.67% in those over 90 years. After age adjustment, more men were treated than women (OR 1.26).The expected number treated in 2017 based on census predictions was 54 075 (an increase of 5897 (12.24%) from 2010). The observed growth of 27.13% was 2.22-fold greater than the rate expected by population changes over the period 2010-2017. The number of patients on medication for glaucoma and ocular hypertension in Scotland is increasing. The rate of increase cannot be explained by changes in the size and age structure of the population alone. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Report this publication

Statistics

Seen <100 times